Navigation Links
Varian, Inc. Reports Third Quarter 2008 Results
Date:7/23/2008

is excluding the adjustments described in

items (1) - (4) above.

(6) $8,987 on an adjusted basis excluding the tax impact of the

adjustments described in items (1) - (3) above.

(7) $17,704 and $0.60 per diluted share, respectively, on an adjusted

basis excluding the adjustments (net of related tax effects)

described in items (1) - (4) above.

(8) $123,075 on an adjusted basis excluding $1,306 in acquisition-related

intangible amortization, $700 in restructuring and other related

costs and $95 in share-based compensation expense.

(9) $60,033 on an adjusted basis excluding $506 in acquisition-related

intangible amortization, $1,919 in restructuring and other related

costs and $1,908 in share-based compensation expense.

(10) $16,466 on an adjusted basis excluding $287 in restructuring and

other related costs and $126 in share-based compensation expense.

(11) $27,521 on an adjusted basis excluding the adjustments described in

items (8) - (10) above.

(12) $9,721 on an adjusted basis excluding the tax impact of the

adjustments described in items (8) - (10) above.

(13) $18,968 and $0.61 per diluted share, respectively, on an adjusted

basis excluding the adjustments (net of related tax effects)

described in items (8) - (10) above.

VARIAN, INC. AND SUBSIDIARY COMPANIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF EARNINGS

(In thousands, except per share amounts)

First Nine Months FY 2008 and First Nine Months FY 2007

Nine Months Ended

-------------------------------

June 27, June 29,

2008 200
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. James T. Glover Appointed to Board of Directors of Varian, Inc.
2. New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS
3. New FT-IR Spectrometer Series from Varian, Inc.
4. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
5. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
6. New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities
7. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
8. Varian, Inc. Reports First Quarter 2008 Results
9. Nuvelo Reports Second Quarter 2008 Financial Results
10. Genzyme Reports Strong Second-Quarter Growth
11. Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008).... 28 /- Truman Medical Centers (TMC),...ates to install the,Siemens SOMATOM Definition AS ...canner is a highly adaptive scanner, providing exc...sure to the patient., "To be one of the first med..., first of its kind, state-of-the-art technology c...
(Date:8/28/2008)...28 /- Barr Pharmaceuticals,...diary, Barr Laboratories,Inc., received final app...A) to manufacture and market a generic version of ...drobromide), 4 mg, 8 mg and 12 mg tablets. Barr,in...ct immediately., Barr filed an Abbreviated New Dr...
(Date:8/28/2008)...st 28 /- ThromboGenics NV,(...ocused on innovative,treatments for eye disease, v...iness update and its financial results for the six...irst half of 2008, ThromboGenics has achieved a nu...ompany to successfully pursue the,next stage of it...
(Date:8/28/2008)... CoreValve ( www.corevalve.com ) announced today t...uation of its proprietary percutaneous ReValving S...mounted in a self-expanding frame, was initiated l...f. (Business Wire EON) August 28, 2008 -- The fir...ystem were performed in two days by John Ormiston,...
Breaking Biology Technology:Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the World's First Adaptive 128-slice CT Scanner 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries 2
...Note: "FORWARD VISIONS" Today we begin three week... will appear on the Wisconsin Technology Network (...igned to stimulate awareness, discussion and debat...houghts and technologies surrounding Wisconsin,s H...ember 1-7. WTN will publish EXCLUSIVE articles and...
...tt would like to be sitting in piles of cash right...n manufacturing) isnt, hell take the latest versio... WorkWise , based in Milwaukee, is a provider of e...o maximize profits through improved use of their i...that more than 100 companies upgraded to the lates...
...has been a leader both in cutting-edge health care...ons leading research universities in UW-Madison, a...E Medical Systems, the state is poised to lead aga...though science and engineering have long contribut...s x-rays for diagnosis or radiation for cancer tre...
...Note: The Wisconsin Technology Network has receiv...cs 60-page report titled, the NorthStar Guide t...report contains a primer for Wisconsin companies s... the state. David Ward and his team have agreed to...over the next three weeks the second installment i...
Other Biology Technology:Why Wisconsin Lags Behind the U.S. and Minnesota 2Why Wisconsin Lags Behind the U.S. and Minnesota 3Why Wisconsin Lags Behind the U.S. and Minnesota 4Why Wisconsin Lags Behind the U.S. and Minnesota 5WorkWise Helps Manufacturers Squeeze Bottom Line 2The Role of Engineering in Health Science and Technology 2The Role of Engineering in Health Science and Technology 3Angel Investing in Wisconsin 2Angel Investing in Wisconsin 3Angel Investing in Wisconsin 4Angel Investing in Wisconsin 5
(Date:8/29/2008)...he skin of unwitting caterpillars belongs to one o... researchers report that its diversity is even hig...slide show on the research, please go to: http://...e .) , By combining ecological and genetic data ...he researchers have dramatically increased nearly...
(Date:8/29/2008)...ainly because they lose control of their growth. T...at Ohio State University,s Comprehensive Cancer Ce...rowth in embryos and that contribute to cancer in ...E2f3b are generally believed to work together to ...es from experiments using only cells. Cancer resea...
(Date:8/28/2008)...rst new living species of giant clam in two decade... August 28th in Current Biology , a Cell Press pu...new species, called Tridacna costata , once accou...e Red Sea, it now represents less than one percent...said they cannot say for sure which factors contri...
(Date:8/28/2008)...earch about national, home and business security s... University of Houston professor and his colleague...mmunity when it comes to surveillance. , Two p...fifth annual Institute of Electrical and Electroni...Video and Signal-Based Surveillance (AVSS). It wi...
Breaking Biology News(10 mins):Diversity among parasitic wasps is even greater than suspected 2Diversity among parasitic wasps is even greater than suspected 3Location, location, location important for genes, too 2New giant clam species offers window into human past 2National security remedies among topics at surveillance confab 2National security remedies among topics at surveillance confab 3Chairman and CEO Bill Marriott to Lead Marriott Employees in Torch Relay to Raise 241 25 Million for Childrens Hospitals Nationwide 4503 1Chairman and CEO Bill Marriott to Lead Marriott Employees in Torch Relay to Raise 241 25 Million for Childrens Hospitals Nationwide 4503 2Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 1Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 2A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 1A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 2A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 3A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 4A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 5A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 6A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 7A fresh look at existing therapies 3A Researchers explore ways to teach approved drugs new tricks 4497 8The conservation lens 947 1The conservation lens 947 2The conservation lens 947 3
...esearchers have developed two new technologies for...rst patent-pending technology provides a way for r...aboratory are responding to an anti-cancer drug. T...s at once -- allows for the simultaneous testing o...g on different kinds of cells taken from the body....
...ad view of evolution as a process played out over ...hown that natural selection can turn on a dime -- ...n a study of island lizards exposed to a new preda...ramatically changed direction over a very short ti...ger and then shorter hind legs. , The findings, by...
... a boost tomorrow (14 October) as CSIRO launches i...ysis software at Neuroscience 2006 in Atlanta, Geo...earchers. , HCA-Vision is based on a proprietary m... for automatically tracing and measuring lines in ...xpected, the conference will be an ideal focus for...
...a recurrent cancer of the central nervous system t..., has shown promising results in preliminary data ...ndings from the first group of six patients in the...search Center, showed that vitespen (trademarked a...n tumor, was associated with tumor-specific immune...
Other Biology News:Chemical tests of cell growth enter third dimension 2Chemical tests of cell growth enter third dimension 3Pressured by predators, lizards see rapid shift in natural selection 2Vaccine for brain tumors shows promising results 2Vaccine for brain tumors shows promising results 3
...of the LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Dif...w-pass Linear Variable Filters to create the world...velength and adjustable bandpass. Each filter feat...cking band (99.8%). These filters -- with interfe...
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Ms anti-Cyclophilin D
Intended to qualitatively detect EGFR gene amplification in formalin-fixed, paraffin-embedded (FFPE) tissue sections, metaphase chromosome spreads, and cell preparations, using Chromogenic In Situ Hy
Biology Products: